US Patent 9649284 Treating critically ill patients with intravenous ibuprofen
Patent 9649284 was granted and assigned to Cumberland Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 13, 2015
0
Date of Patent
May 16, 2017
0
Patent Applicant
Patent Application Number
14825803
0
Patent Inventor Names
Leo Pavliv
0
Amy Dix Rock
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9649284 Treating critically ill patients with intravenous ibuprofen
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.